Publicaciones (71) Publicaciones en las que ha participado algún/a investigador/a

2008

  1. A Content-Centric Development Process Model

    Computer, Vol. 41, Núm. 3, pp. 24-30

  2. Antiretroviral drugs and liver injury

    AIDS, Vol. 22, Núm. 1, pp. 1-13

  3. Antiretroviral-associated portal hypertension: A new clinical condition? Prevalence, predictors and outcome

    Antiviral Therapy, Vol. 13, Núm. 1, pp. 103-107

  4. Aprendizaje basado en juegos en entornos e-learning

    Novática: Revista de la Asociación de Técnicos de Informática, Núm. 193, pp. 13-17

  5. Association between tipranavir plasma levels and virological response in HIV-infected patients

    AIDS Research and Human Retroviruses, Vol. 24, Núm. 3, pp. 389-391

  6. Building adaptive game-based learning resources: The integration of IMS Learning Design and <e-Adventure>

    Simulation and Gaming, Vol. 39, Núm. 3, pp. 414-431

  7. Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-Hepatitis B Virus International Panel

    AIDS, Vol. 22, Núm. 12, pp. 1399-1410

  8. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

    Clinical Infectious Diseases, Vol. 46, Núm. 7, pp. 1101-1110

  9. Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir

    Clinical Infectious Diseases, Vol. 46, Núm. 11, pp. 1782-1785

  10. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

    AIDS, Vol. 22, Núm. 3, pp. 367-376

  11. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain

    Blood Coagulation and Fibrinolysis, Vol. 19, Núm. 5, pp. 333-340

  12. Current trends in screening across ethnicities for hypersensitivity to abacavir

    Pharmacogenomics, Vol. 9, Núm. 10, pp. 1531-1541

  13. Diagnóstico de las infecciones por subtipos no B del VIH-1 y por VIH-2

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 13, pp. 66-70

  14. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon α2a or α2b

    Antiviral Therapy, Vol. 13, Núm. 4, pp. 511-517

  15. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?

    Antiviral Therapy, Vol. 13, Núm. 1, pp. 97-102

  16. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4+ cells after antiretroviral therapy

    Journal of Infectious Diseases, Vol. 198, Núm. 10, pp. 1466-1473

  17. Educational game design for online education

    Computers in Human Behavior, Vol. 24, Núm. 6, pp. 2530-2540

  18. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy

    AIDS, Vol. 22, Núm. 14, pp. 1779-1787

  19. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: Final results of the SLOAT trial

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 200-205

  20. Efficacy of pegylated interferon plus ribavirin treatment in HIV/ hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1365-1373